Delivery Order SPE2DB20D7066-SPE2DB24FC1WW
Award Date 2/23/24
Potential Completion Date 2/26/24
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Jolessa 0.15 mg-0.03 mg tablets. The $1,109.49 firm fixed-price contract has an ultimate completion date of October 8, 2024. Amerisourcebergen is the prime contractor, and there is no set-aside designation indicated. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a $1,663.68 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of 4565221558 JOLESSA 0.15 MG-0.03 MG TABLET 91S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which provides a comprehensive range of medical commodities to support military treatment...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide JOLESSA TABS 3X 91S pharmaceuticals. The $7,934.25 delivery order has a completion date of February 6, 2024 and was awarded on January 9, 2024. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA to supply pharmaceuticals, medical supplies, and...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JOLESSA 0.15 MG-0.03 MG TABLET 91S, a pharmaceutical product, with a ceiling value of $1,035.84 and a performance period ending on May 28, 2025. The contract is a Firm Fixed Price (FFP) delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical products on September 24, 2025, with an ultimate completion date of September 25, 2025. The contract covers the supply of Jolessa 0.15 mg-0.03 mg tablets (91-count), a hormonal contraceptive medication, with a ceiling value of $1,545.28. This delivery order is issued under a firm fixed-price arrangement with no set-aside designation, indicating competitive award to the qualified vendor. The...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,136.93 by the Defense Logistics Agency (DLA) on October 31, 2025, for the supply of Jolessa Tabs 3X 91S, a hormonal contraceptive medication. The contract is a firm fixed-price delivery order with an ultimate completion date of December 1, 2025, and was awarded on a competitive basis without a set-aside designation. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for supply of Jolessa 0.15 mg-0.03 mg tablets (91 count) under a firm fixed price contract with a ceiling value of $1,836.60. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of December 18, 2025. The place of performance is the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,727.16, is for the delivery of the prescription medication JOLESSA 0.15 MG-0.03 MG TABLET 91S. The contract has an ultimate completion date of September 12, 2022 and is a firm fixed-price contract. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is a...
- This federal contract award, with ID SPE2DB20D7066|SPE2DB25FC2DP, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,203.28 firm-fixed-price delivery order is for the supply of JOLESSA 0.15 MG-0.03 MG TABLET 91S, a pharmaceutical product. The contract has an ultimate completion date of January 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of JOLESSA 0.15 MG-0.03 MG TABLET 91S to the Defense Logistics Agency (DLA). The $1,222.96 firm fixed price delivery order was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 4, 2024, with an ultimate completion date of October 7, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp's Corporate Office Division is the prime contractor for this award, which is associated with...